Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase 2 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 5OTHER_GOV 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Pain 2

Interventions

Carboplatin 315Paclitaxel 303Cisplatin 250Docetaxel 238pembrolizumab 230Gemcitabine 214Pemetrexed 158Capecitabine 147Rituximab 144Bevacizumab 142Dexamethasone 125Fluorouracil 121Cyclophosphamide 102Trastuzumab 100Doxorubicin 96Nivolumab 93Prednisone 92Oxaliplatin 90atezolizumab 75Leucovorin 72durvalumab 69130-nm albumin-bound paclitaxel 68Injections 66Lenalidomide 63Irinotecan 62Bortezomib 56Letrozole 54Topotecan 53Fulvestrant 53Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × INDUSTRY × Hydromorphone × Clear all
NCT01205126 2014-02-03

An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3 Completed
260 enrolled 12 charts

Pain

NCT00822614 2009-01-14

FINDS

Akela Pharma, Inc.

Phase 3 Unknown
500 enrolled

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡